Inflammatory bowel diseases (IBD) are key risk factors for the development of colorectal cancer, but the mechanisms that link intestinal inflammation with carcinogenesis are insufficiently understood. Card9 is a myeloid cell-specific signaling protein that regulates inflammatory responses downstream of various pattern recognition receptors and which cooperates with the inflammasomes for IL-1β production. Because polymorphisms in Card9 were recurrently associated with human IBD, we investigated the function of Card9 in a colitis-associated cancer (CAC) model. Card9 −/− mice develop smaller, less proliferative and less dysplastic tumors compared to their littermates and in the regenerating mucosa we detected dramatically impaired IL-1β generation and defective IL-1β controlled IL-22 production from group 3 innate lymphoid cells. Consistent with the key role of immune-derived IL-22 in activating STAT3 signaling during normal and pathological intestinal epithelial cell (IEC) proliferation, Card9 −/− mice also exhibit impaired tumor cell intrinsic STAT3 activation. Our results imply a Card9-controlled, ILC3-mediated mechanism regulating healthy and malignant IEC proliferation and demonstrates a role of Card9-mediated innate immunity in inflammation-associated carcinogenesis.
Introduction
Inflammatory bowel diseases (IBDs) such as Crohn's disease and ulcerative colitis are relapsing and remitting disorders, which are most prevalent in the Western world. The chronic inflammatory state within the intestine results in a debilitating disorder and in addition predisposes to the development of colitisassociated cancer (CAC), which is a major cause of death in IBD patients [1] . Data from epidemiologic and genetic studies indicate a deregulated innate immune response against intestinal microbes in a genetically susceptible host as the underlying cause of IBD, but the signals and immune mechanisms that promote CAC growth are still insufficiently defined. Candidate gene searches of innate immune pathways in IBD identified associations of Card9 gene polymorphisms (rs10870077) with Crohn´s disease and ulcerative colitis [2] , confirmed by genome-wide association studies [3] [4] [5] . The Card9 gene encodes for a cytoplasmic adaptor protein, which is selectively expressed in myeloid-derived innate immune cells [6, 7] . It belongs to a small family of Caspase recruitment domain (CARD) containing proteins that also includes the lymphocyte specific member Card11 (Carma1), and which assemble immune signaling complexes for context-specific NF-κB and Mitogen-activated protein kinases (MAPK) activation [7] [8] [9] . The Card9 module cooperates with inflammasomes in antigen presenting cells (APCs) [7] , to induce the generation of pro-IL-1β, which is subsequently cleaved into bioactive IL-1β. It also regulates the production of other cytokines including IL-6, which all together orchestrate the differentiation of activated T cells towards Th-17 immune responses during systemic or local fungal or bacterial infection [10] [11] [12] [13] [14] [15] . However, the pathophysiological importance of these pathways in inflammatory diseases is still ill defined and their role in inflammation-associated cancer is unknown.
Multiple pattern recognition receptors (PRRs) of the C-type lectin receptor (CLR) family including the anti-fungal receptor Dectin-1 require Card9 for the activation of innate immunity. Card9-signaling is also responsive to sterile cell death and to the stimulation of nucleotide-oligomerization domain (Nod) 2 or cytoplasmic viral nucleic acid sensors such as Rig-I or Rad50 [7, 13] . Interestingly, polymorphisms in Dectin-1 and in Nod2 are similar to Card9 polymorphisms associated with human IBD [5, 16, 17] , indicating that these signaling pathways play important roles in intestinal mucosal immunity. In line with these findings, Card9-signaling has been implicated in intestinal immune responses and the maintenance of homeostasis after epithelial injury and bacterial infection in mice [14] . Therefore, we here investigated the function of Card9-mediated innate immunity in inflammation-associated colon carcinogenesis. We report that Card9-signaling drives the production of IL-1β within the damaged intestine and regulates the subsequent generation of IL-22 by group3 innate lymphoid cells, which promotes tumorigenesis via STAT3 activation within the transformed epithelium.
Results

Reduced colitis-associated tumor growth in Card9-deficient mice
To study the role of Card9 in CAC, we injected Card9 −/− mice with one dose of the genotoxic carcinogen Azoxymethane (AOM) to induce mutations in intestinal epithelial cells (IECs), followed by three cycles of feeding with the detergent Dextran Sodium Sulfate (DSS) (Fig. 1A) . DSS-treatment causes epithelial injury and subsequent colonic inflammation that drives intestinal epithelial dysplasia after AOM treatment [18] [19] [20] . We assessed colitis severity by daily weighing the mice. During the first round of DSS-treatment, Card9 −/− mice lost less weight compared to their wild type littermates ( Fig. 1A ) while no differences in systemic inflammatory TNF, IL-6, IL-2 and IL-1β responses were detected during the acute phase of colitis (Fig. 1B) . However, during the second and third cycle of DSS treatment, Card9 −/− mice displayed a higher loss of body weight ( Fig. 1A ) with finally increased systemic TNF, IL-6, IL-2 and IL-1β concentrations (Fig. 1B) and a delayed and insufficient recovery from the DSS challenge (Fig. 1A ). Consistently and in line with previously published results [14, 21] , Card9-deficient mice showed a delayed recovery following prolonged DSS administration in an acute colitis model (data not shown). About 40% of all Card9 −/− mice had to be sacrificed before day 68 of the experiment (Fig. 1C) . Sacrificed Card9 −/− mice had dilated colons without macroscopically visible polyps and were filled entirely with luminal content indicative of a paralyzed colonic muscle layer, which can occur as a life-threatening complication of severe intestinal inflammation. At day 68 after initial AOM treatment, we sacrificed all remaining animals for detailed analysis. As expected, the WT animals developed multiple large polyps in their distal colons [18] [19] [20] , but the colonic polyps in Card9 −/-mice appeared macroscopically smaller in size. Histological analysis revealed a hyperplastic and regenerating epithelium in WT mice, whereas Card9 −/− mice showed broad areas of epithelial abrasion with ulcers, edema and mucosal infiltration with Ly6G + neutrophils (Supporting Information Fig. 1A ), which was also observed in the animals that were prematurely sacrificed (data not shown), consistent with defects in epithelial regeneration. To test whether mucosal barrier defects contribute to epithelial damage in Card9-deficient mice, we stained for acidic and neutral mucins in the inflamed epithelia and found an equal distribution between WT and Card9 −/− animals (Supporting Information Fig. 1B ).
To characterize the tumor growth in a quantitative manner, we performed serial colon sections for histology. In Card9-deficient animals we detected a significant reduction in the size of polyps and a lower degree of dysplasia characterized by less elongated and less crowded nuclei with more preserved polarity and crypt architecture in comparison to WT mice ( Fig. 2A and B) . Yet, the total number of neoplasms per mouse did not differ between WT and Card9 −/− mice ( required for signals that promote tumor growth. To test whether Card9 signaling would control the proliferation of normal and transformed intestinal epithelial cells, we performed immunohistochemical analysis of BrdU incorporation into IECs. We observed significantly reduced numbers of BrdU-positive, proliferating cells per crypt within the tumors and also in the untransformed epithelia of Card9 −/-mice (Fig. 2D) . Because an increased susceptibility to epithelial cell apoptosis could additionally contribute to the observed phenotype, we also studied caspase-3 activation within the epithelium. While we detected an increase in the frequency of apoptotic cells in the inflamed epithelia of Card9 −/-mice compared to WT mice (Fig. 2E left) , active caspase-3 staining did not differ in the tumor regions (Fig. 2E right) 
not differ between DSS-treated WT and Card9
−/− mice (Fig. 3A ).
This finding is in line with the fact that Card9 is not expressed within IECs but specifically in leukocytes as indicated in previous studies [7, 9, 27, 28] . Next, we investigated the leukocyte intrinsic expression of cytokines that drive or induce tumor-promoting Th17 cell and IL-22-mediated immune responses. Intriguingly, IL-1β mRNA expression within leukocytes isolated from the colonic lamina propria was almost completely abolished in mice lacking Card9 (Fig.  3B) . Moreover, we also observed a reduced IL-1β protein production in ex vivo colon cultures from AOM/DSS-treated Card9-deficient mice at day 68 of the experiment (Supporting Information Fig. 2 ). In addition, and consistent with the function of Card9 signaling and IL-1β production in promoting Th17 cell differentiation [10, 15, [29] [30] [31] [32] [33] , the expression of IL-17A within lamina propria leukocytes was also almost completely abolished in Card9 −/− animals ( Fig. 3B) .
IL-1β does not only regulate Th17-responses, but also maintains and enhances the production of IL-22 by innate lymphoid cells [34] [35] [36] [37] , which is a key growth factor for intestinal epithelial cells [38] in inflammatory disease wound healing and tumorigenesis [39] . Consistent with a lack in IL-1β production during the recovery phase after colitis, Card9 −/− mice expressed significantly less IL-22 in lamina propria leukocytes (Fig. 3B ). To test whether elevated TNF contributes to increased DSS-mediated colitis and colonic epithelial cell death in Card9 −/− animals, we also analyzed TNF expression during acute DSS colitis. However, TNF expression was also significantly reduced in lamina propria leukocytes of DSS treated Card9 −/− mice (Fig. 3B ).
Card9 signals regulate IL-22 production from type 3 innate lymphoid cells
IL-22-producing lymphoid cells migrate to and are activated in the lamina propria during inflammation. They are also frequently detected in human colorectal cancer and play a tumor-promoting role in the disease [39, 40] . IL-22 signals through its heterodimeric receptor, which is exclusively expressed on non-immune cells and which induces IEC proliferation during tissue repair. IL-22 signaling can promote malignancy in tumor cells and the neutralization of IL-22 can directly reduce the level of dysplasia and tumor growth [39] . Because the predominant source of IL-22 in the intestinal mucosa are type 3 innate lymphoid cells (ILC3) [37] , we investigated IL-22-production by ILC3s within the intestines of Card9 −/− mice using flow cytometry. We also studied IL-17 or IFN-γ generation by ILC3s, or IFN-γ production by ILC1s, which constitute together with ILC3s the main ILC subsets within the gastro-intestinal tract. Interestingly, the frequency of IL-22-producing ILC3s did not differ between wild-type and Card9-deficient mice under homeostatic conditions (Fig. 4A ). Yet, during the regeneration phase after DSS challenge, the percentage of IL-22-producing ILC3s was significantly reduced in Card9 −/− mice compared to the wild-type specifically within the colon (Fig. 4A ), but not in the small intestine (Fig. 4B ). 
CD103
− CD11b + , CD103 + CD11b − , and CD103 + CD11b + DCs (Fig. 5B, C and Supporting Information Fig. 3A) , further indicating that pure developmental APC defects are unlikely to account for the defective IL-22 response in ILC3s. Because myeloid derived IL-1β controls the production of IL-22 by ILCs together with IL-23 [34, 35, 37] , we next investigated IL-23 expression in Card9-deficient leukocytes during DSS colitis. Yet, in contrast to defective IL-1β production (see above, Fig. 3B and Supporting Information Fig. 2 ), IL-23 is regularly expressed in Card9-deficient lamina propria leukocytes (Fig. 5D) . Together, these data suggest that the Card9-mediated generation of IL-1β by myeloid cells within the inflamed tissue secondarily drives the production of IL-22 by Card11 expressing ILCs. To test this model, we isolated lamina propria leukocytes from Card9 
Card9
−/− animals are not intrinsically defective in IL-22 production, indicating that the failure to provide myeloid-derived IL-1β is a cause for the defective IL-22 production in Card9-deficient mice.
Reduced tumor cell intrinsic STAT3 signaling in Card9-deficient animals
Binding of IL-22 to the IL-22-receptor on IECs activates JAK/STAT signaling, mainly STAT3, by inducing its phosphorylation.
Subsequently, activated STAT3 is essential to induce the expression of a plethora of target genes within the IEC compartment that mediate mitogenic and regenerative activities both under physiological and pathogenic conditions [39, 44, 45] . Consistently, mice with an IEC-specific deletion of STAT3 recover later from colitis with epithelial abrasion and develop smaller tumors in CAC-models similar to Card9 deficient animals [44, 46] Fig. 6A and B) . Other cytokines and growth factors such as IL-6, IL-11 and VEGF are also potent activators of STAT3-signaling in IECs. We therefore analyzed the expression of these cytokines in colonic tissues from AOM/DSS-treated WT and Card9 −/-mice, but detected no statistically significant differences (Supporting Information Fig.  4A-C) . Together, these results indicate that the failure to fully activate STAT3 signaling within IECs accounts for the reduced tumor growth and defective epithelial cell regeneration in Card9
mice.
Discussion
In our study we demonstrate a previously unrecognized role for Card9 in the regulation of intestinal immune responses and in the promotion of colitis-associated cancer. The impaired production of IL-1β in Card9-deficient mice after inflammatory challenge is associated with a defective induction of a major regenerative and tumor-promoting pathway in the intestine that operates through IL-22 signaling and the STAT3 pathway. Based on our findings, we propose the following model for Card9 function during colitis-associated cancer development (see also Fig. 6C IL-17. Thus, it is highly likely that such factors would overcome a pure IL-22 deficiency and drive inflammation-mediated tumor growth in the Il-22 −/− mice. Moreover, as we could not detect any defects in the innate cytokine IL-23 in leukocytes from the intestine of Card9 −/− mice, we propose that the impaired induction of intestinal IL-22, IL-17 and TNF in these animals is caused by attenuated IL-1β-signaling, which was shown to be an inducer of IL-22, IL-17 and TNF expression [10, 15, 35, 37, 48, 49] . Consistently, former studies have also implicated a role for the Th17 cell cytokine IL-17 in the promotion of tumor growth in the intestine [50] . Nevertheless, only the acute neutralization of IL-22 with antibodies was able to reduce dysplasia and colorectal cancer growth, while a blockage of IL-17 only inhibited some parameters of intestinal inflammation including splenic mass [39] demonstrating a predominant role of IL-22 in the maintenance of the disease [39] . Thus, we hypothesize that despite the significant reduction of IL-17 in lamina propria leukocytes from the intestine of Card9 −/− mice, the impairment in IL-22 production is the major cause for the reduced dysplasia and retarded tumor growth. During the preparation of this manuscript, an independent report has also demonstrated that Card9 −/− mice exhibit a reduction in the percentage of IL-22 + cells in the lamina propria of the colon after DSS treatment, resulting in defective healing and increased susceptibility to colitis [21] . These findings are consistent with our data and further support our concept. In addition, while Lamas et al. did not study the function of these mechanisms during inflammation-triggered oncogenesis, they could elegantly demonstrate a critical function for Card9 in the control of the composition of the gut microbiome. In their study, the altered microbiome in Card9 −/− mice is impaired in the metabolism of tryptophan into indole derivates, which act as AHR ligands and promote local IL-22 production. We continuously co-housed Card9-deficient mice and littermate controls from birth on, to minimize effects of genotype on the microbiota. Nevertheless, based on the current study by Lamas et al. [21] , it is conceivable that decreased levels of bacteria that have tryptophan-catabolizing functions in Card9 −/− mouse microbiota might additionally affect tumor growth through IL-22 regulation. Furthermore, other Card9-mediated pro-inflammatory mediators are likely to contribute to tumor pathogenesis. Additional investigations are required to precisely dissect the individual contribution of the different Card9 effector mechanisms including inflammatory cytokines that regulate IL-22 and collaborate in the promotion of colitis-associated cancer. Because a growing number of studies have identified Card9 polymorphisms in IBD patients, and IBD is a strong risk factor for colorectal cancer development [2] [3] [4] [5] 51] , dysfunctional Card9-regulated immune pathways could contribute to CAC in humans and could as such constitute a target for therapeutic intervention. Moreover, given that the pathogenic role of aberrant STAT3-signaling in multiple tumor types is well established [52] and because the IL-22 receptor is also expressed by other cell types including hepatocytes, lung epithelial cells or keratinocytes [53] , Card9-induced pathways that induce IL-22 signaling may also impact on other adeno-or squamous cell carcinomas.
Materials and methods
Mice, induction of CAC, and acute colitis
Card9 −/− mice were generated by our laboratory and described earlier [8] . All mice were kept under specific pathogen free conditions. Card9 −/− and WT mice were cohoused for at least 3 weeks before and throughout the experiments to minimize variations in the endogenous microbiota.. We therefore used only female mice in all experiments. Azoxymethane (Sigma) was injected intraperitoneally (i.p.) once at 10 mg/kg, followed by three cycles of 3.5% Dextran sulfate sodium salt (MP Biomedicals) in the drinking water for five continuous days at days 5, 26, and 47. For acute DSS colitis, mice were given DSS for 7 days in the drinking water followed by 5 days of water. Mice suffering from weight loss higher than 20% of their initial weight or showing indication of illness were euthanized by cervical dislocation. In order to monitor proliferation of IECs, mice were injected intraperitoneally with Bromodeoxyuridine (BrdU) (Sigma) at 75 mg/kg 12 h prior to sacrifice. For systemic cytokine analysis, blood was collected by submandibular bleeding. All procedures were reviewed and approved by the Regierung von Oberbayern.
Histological analysis
Colons were prepared as 'Swiss rolls' and formalin-fixed for 24 h. For histopathological analysis 2 μm-thick serial sections (every 200 μm) of paraffin-embedded colons were subjected to Hematoxylin & Eosin (H&E) staining according to standard procedures. BrdU-incorporation was detected using antibromodeoxyuridine antibody (AbD Serotec; MCA2060) according to standard immunohistochemical procedures. Automated immunohistochemical staining for cleaved caspase-3 (Cell Signalling, #9661, Asp175), Ly6G (BD Pharmingen, 551459, monoclonal (1A8)) and phospho-STAT3 (Cell Signaling, #9145, Tyr705) was performed using a BondMax staining machine (Leica). Hematoxylin was used for counterstaining. Images were acquired using an Olympus SZX12 microscope equipped with a JVC digital camera and using the image processing software cellSens. For tumor quantification and tumor sizes, H&E-stained slides of colonic serial sections were scanned using a SCN400 Slide scanner (Leica) and analyzed using TissueIA image analysis software (Slidepath, Leica). The area of every single tumor was measured on the slide with the biggest tumor diameter of all serial sections from a specific mouse. The loss of cellular integrity during apoptosis required quantification of apoptosis by measuring the positive stained pixel in confined region of interest (ROI) areas discriminating epithelial and tumor regions for each mouse. BrdU incorporation and STAT3 activation in IECs was evaluated by counting at least five crypts per tumor or epithelium field in three fields/mouse of at least four animals per group. Researchers were blinded to sample identity for histological analysis.
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Gene expression analysis
Total RNA was isolated with Trizol (Invitrogen) followed by further purification using the RNeasy Mini Kit (Qiagen) and transcribed into cDNA using Superscript II reverse transcriptase ( 
Ex vivo colon culture
After AOM/DSS-treatment, colons from WT and Card9 −/− mice were removed and cultured ex vivo as described by Zenewicz et al. [54] . On day 3, supernatants were harvested and stored at -80°C until analysis of cytokine concentrations by cytometric bead array (BD).
Isolation of lamina propria leukocytes and FACS staining for cytokine production in ILCs
The isolation of lamina propria leukocytes followed by immunofluorescence staining and flow cytometric analysis has been previously described [55] . Fluorophore-conjugated antibodies for flow cytometry and reactive to mouse antigens were purchased from eBioscience unless otherwise indicated: CD3 (145-2C11), CD19 (1D3), CD45 (30F11), CD127 (A7R34), IL-22 (1H8PWSR), IL-17A (TC11-18H10; BD Biosciences), RORγt (B2D), IFN-γ(XMG1.2), and T-bet (eBIO 4B10).
Card gene expression in ILC2 and ILC3 subsets
Microarrays for the expression of Card9 and Card11 in ILC3 and ILC2 subsets were performed as previously described by Hoyler et al. [56] .
Isolation of mesenteric lymph node cells, ex vivo stimulation and flow cytometric analysis of IL-22 production
MLNs were dissected and incubated in HBSS (Ca 2+ ; Mg 2+ ) supplemented with 2% FCS, 2 mg/mL Collagenase D (Roche) and 0.12 mg/mL DNase I (Roche) for 30 min at 37°C. The cell suspension was incubated for 7 min with red blood cell lysis solution (eBioscience) on ice (1 mL/mouse) and plated in complete RPMI (RPMI supplemented with 10% FCS, 1% L-Glutamine, 1% Penicillin/Streptomycin and 0.1% 2-Mercaptoethanol, all from Gibco) at a cell concentration of 2 × 10 6 /mL on a 96-well plate 
Statistical analysis
Data were analyzed and graphed using Excel (Microsoft Office) and Prism (GraphPad Software). For comparison between two groups two-tailed Student's t-test was used. Survival data were analyzed using the log-rank test. The level of significance was defined as * p < 0.05 and *** p < 0.001.
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